
Keywords: Synthetic lethality; Epigenetics; High-throughput screening; Genomics; Signaling networksATM, ataxia telangiectasia, mutated; ATR, ATM and Rad3-related; ATRIP, ATR-interacting protein; BAF, Brg1-associated factor; BER, base excision repair; BRCA1, breast